ACTRN12609000558224
Completed
Phase 2
A double blind randomised placebo controlled clinical trial testing the effectiveness of a Chinese herbal medicine extract formulation for constipation-predominant Irritable Bowel Syndrome.
niversity of Western Sydney0 sites160 target enrollmentJuly 8, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Constipation-predominant Irritable Bowel Syndrome
- Sponsor
- niversity of Western Sydney
- Enrollment
- 160
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Have a normal colonic evaluation test within the previous 5 years (colonoscopy or barium enema, or other colonic imaging).
- •2\. Normal blood test results (full blood count, liver function test, urea \& creatinine) performed within the last 3 months.
- •3\. Confirmed C\-IBS diagnosis by a Gastroenterologist or General Practitioner (GP).
Exclusion Criteria
- •1\. Pregnancy or breast\-feeding.
- •2\. Significant cardiovascular, renal, hepatic, pulmonary, endocrine, metabolic, or haematological disorders.
- •3\. Diabetes mellitus requiring insulin therapy.
- •4\. Epilepsy.
- •5\. Inflammatory bowel disease.
- •6\. Gastrointestinal tract neoplasm.
- •7\. Celiac disease (by Tissue Transglutaminase (TTG) performed in the previous five years).
- •8\. Current psychiatric illness or dementia (excluding clinically diagnosed depression or anxiety where the patient has been stable on medication for at least three months).
- •9\. Current alcoholism or drug abuse.
- •10\. Previous bowel surgery (excluding appendectomy, cholecystectomy, fundoplication).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
A double blind randomised placebo controlled clinical trial for evaluating the efficacy of Eranda Patra Kshara and Hingu churna with lifestyle modification in the management of Non-alcoholic fatty liver diseaseCTRI/2023/04/052096All India Institute of Ayurveda
Completed
Not Applicable
A randomised placebo controlled double blind clinical trial of vitamin D in the treatment of tuberculosisTuberculosisInfections and InfestationsISRCTN35212132Bandim Health Project (Guinea-Bissau)500
Completed
Not Applicable
A randomised placebo controlled double blind clinical trial comparing selenium and pentoxifylline in patients with mild Graves' orbitopathy - EUGOGO study BISRCTN16320108Academic Medical Centre (AMC) (The Netherlands)156
Completed
Phase 2
Complementary and Alternative Medicine and the menopausal transition: The effect of a Chinese Herbal Formula on Vasomotor symptoms and bone turnover.ACTRN12608000617369Global Therapeutics Pty Ltd90
Completed
Phase 3
Rituximab in patients with primary Sjögren's syndromeISRCTN65360827niversity of Leeds (UK)110